Alert detail
LCD L39948: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis — Noridian
What changed
New LCD for hereditary transthyretin amyloidosis testing.
Who’s affected: Genetic Testing billing teams · Effective: February 5, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 4 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.